Stocks
ABIOMED (ABMD) EBITDA margin US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2022 | LTM ? | CAGR 5 years ? | |||||
| EBITDA margin, % | ? | 29.1% | 18.5% | 38.8% | 26.5% | ||||
| Changes by years, y/y, % | -1pp | -29pp | +20pp | +12.1% | |||||
ABIOMED. EBITDA margin, %
ABIOMED. EBITDA margin, changes, pp
ABIOMED (ABMD) EBITDA margin US GAAP (quarter values) |
||||||||
| 2022Q3 | 2022Q4 | 2022Q4 | 2023Q1 | 2023Q2 | LTM ? | |||
| EBITDA margin, % | ? | 27.4% | 27.7% | 27.9% | 26.2% | 24.3% | 26.5% | |
| Changes by years, y/y, % | -10pp | -6pp | -5pp | +27pp | -2pp | |||
| Changes by quarters, q/q, % | +3pp | +0pp | +0pp | -2pp | -2pp | |||
